Bruker Corporation provided revenue guidance for the second quarter 2022. For the second quarter of 2022, outlook is for organic revenue growth in the mid- to high single digits year-over-year, subject, of course, to further COVID-related lockdowns in China or other geopolitical risks, which could negatively impact that growth.